Walgreens Boots Alliance Management

Management criteria checks 1/4

Walgreens Boots Alliance's CEO is Tim Wentworth, appointed in Oct 2023, has a tenure of 1.08 years. directly owns 0.019% of the company’s shares, worth ARS1.34B. The average tenure of the management team and the board of directors is 1.3 years and 3.1 years respectively.

Key information

Tim Wentworth

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	1.1yrs
CEO ownership	0.02%
Management average tenure	1.3yrs
Board average tenure	3.1yrs

Recent management updates

Recent updates

CEO

Tim Wentworth (64 yo)

1.1yrs

Tenure

Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Stefano Pessina	Executive Chairman of the Board	12.6yrs	US$7.57m	0.096% ARS 6.9b
Manmohan Mahajan	Executive VP & Global CFO	1.3yrs	US$1.83m	0.048% ARS 3.4b
Ornella Barra	Chief Operating Officer of International	no data	US$5.43m	0.25% ARS 17.8b
Timothy Wentworth	CEO & Director	1.1yrs	no data	0.019% ARS 1.3b
Todd Heckman	Senior VP	1.3yrs	no data	0.0019% ARS 137.3m
Neal Sample	Executive VP & Chief Information Officer	less than a year	no data	0.0066% ARS 470.7m
Tiffany Kanaga	Vice President of Global Investor Relations	no data	no data	no data
Matthew D'Ambrosio	Senior VP and Global Chief Compliance & Ethics Officer	no data	no data	no data
Lanesha Minnix	Executive VP & Global Chief Legal Officer	less than a year	no data	no data
Elizabeth Burger	Executive VP & Chief Human Resources Officer	no data	no data	no data
Liyue Wu	Head of M&A - Asia	no data	no data	no data
Tracey Brown	Executive VP	3yrs	no data	0.0087% ARS 620.9m

1.3yrs

Average Tenure

53.5yo

Average Age

Experienced Management: WBA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Stefano Pessina	Executive Chairman of the Board	12.6yrs	US$7.57m	0.096% ARS 6.9b
Timothy Wentworth	CEO & Director	1.1yrs	no data	0.019% ARS 1.3b
Ginger Graham	Lead Independent Director	14.6yrs	US$366.85k	0.00025% ARS 17.9m
Valerie Jarrett	Independent Director	4.1yrs	US$300.00k	0.00052% ARS 37.2m
Nancy Schlichting	Independent Director	18.1yrs	US$319.97k	0.0024% ARS 175.2m
John Lederer	Independent Director	9.6yrs	US$315.00k	0.0058% ARS 413.4m
Bryan Hanson	Independent Director	2.1yrs	US$84.62k	0.0036% ARS 255.4m
Janice Babiak	Independent Director	12.6yrs	US$325.00k	0.00014% ARS 10.0m
William Shrank	Director	less than a year	no data	0.00041% ARS 29.3m
Inderpal Bhandari	Independent Director	2.2yrs	US$115.29k	0.00035% ARS 25.0m
Thomas Polen	Director	1.3yrs	US$14.13k	0.0019% ARS 136.6m
Robert Huffines	Independent Director	less than a year	no data	no data

3.1yrs

Average Tenure

65yo

Average Age

Experienced Board: WBA's board of directors are considered experienced (3.1 years average tenure).

Walgreens Boots Alliance Management

Management criteria checks 1/4

Key information

Recent management updates

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Walgreens Announces Executive Appointments

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Recent updates

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on December 12, 2024

Walgreens Boots Alliance, Inc. Expects to Close Approximately 1,200 Stores over the Next 3 Years with About 500 Targeted to Close in Fiscal 2025

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Walgreens Appoints Jason Stenta as SVP and Chief Commercial Officer

Saxena White P.A. Files New Securities Fraud Class Action Lawsuit Against Walgreens Boots Alliance, Inc. and Certain of its Executives

Walgreens Boots Alliance, Inc. to Report Q4, 2024 Results on Oct 15, 2024

Walgreens Announces Executive Appointments

Gross Law Firm Announces Lawsuit Against Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on September 12, 2024

Boots Chief Quits Reportedly After Walgreens' Sale Plan Stalls

Walgreens Boots Alliance, Inc. to Report Q3, 2024 Results on Jun 27, 2024

Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray

Walgreens Reportedly Contacts Potential Buyers for £7 Billion Boots Drugstore Chain

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Walgreens Boots Alliance, Inc. Announces Executive Changes

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Walgreens Boots Alliance, Inc. Announces CEO Changes

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023

Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc. Announces Resignation of William Foote, the Board Lead Independent Director

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into a definitive agreement to acquire remaining 45% stake in CareCentrix, Inc. for approximately $390 million.

John Standley to Leave as Executive Vice President of Walgreens Boots Alliance, Inc. on November 1, 2022

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire additional 30% stake in Shields Specialty Pharmacy Holdings, LLC from Welsh, Carson, Anderson & Stowe, Jack Shields & others for approximately $1.4 billion.

Walgreens Boots Alliance, Inc. to Report Q4, 2022 Results on Oct 13, 2022

Walgreens Boots Alliance, Inc. Announces Executive Appointments

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) completed the acquisition of a 55% stake in CareCentrix, Inc.

Walgreens Boots Alliance, Inc. Names Alethia Jackson Senior Vice President, ESG and Chief DEI Officer

Walgreens Boots Alliance, Inc. Announces Resignation of David J. Brailer as Member of the Board of Directors

Jnd Legal Administration Announces A Class Action Lawsuit in the U.S. District Court for the District of Arizona Against Defendants Theranos, Inc., Walgreens Boots Alliance, Inc. and Walgreen Arizona Drug Company

Walgreens Boots Alliance Increases Quarterly Dividend, Payable September 9, 2022

Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of Its Successful Boots Business

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Walgreens Boots Alliance, Inc. to Report Q3, 2022 Results on Jun 30, 2022

Walgreens Reportedly Gives A Few Extra Days for Bidders to Firm Up Offers

An unknown buyer acquired 2.9% stake in AmerisourceBergen Corporation (NYSE:ABC) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $900 million.

Walgreens Boots Alliance, Inc. Reaches Opioid Settlement with State of Florida

Walgreens Reportedly Sets Deadline for Bids in Boots Auction

Reliance Industries Reportedly Studying Possible Bid for Walgreens' Boots Chain

Private Equity Giant Reportedly Abandons Boots Takeover

Walgreens Boots Alliance, Inc. Appoints Steven J. Shulman to Its Board of Directors

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 11, 2022

Bain and CVC Reportedly to Team Up for Boots Bid

Oak Street Real Estate Capital, LLC acquired 1.68-acre property at 3600 Winter Garden Vineland Road in Winter Garden from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for $5.2 million.